Home » Topics » Regulatory

Regulatory
RSS

Aplidin approved in Australia for the treatment of multiple myeloma

Dec. 12, 2018

FDA approves Dextenza intracanalicular insert to treat postsurgical ocular pain

Dec. 3, 2018

Precedex approved for use in pediatric patients in Japan

Nov. 30, 2018

Melinta Therapeutics granted marketing authorization for Vabomere in Europe

Nov. 28, 2018

FDA grants accelerated approval to Vitrakvi for advanced solid tumors with NTRK gene fusion

Nov. 27, 2018

European Commission approves pegfilgrastim biosimilar Pelmeg

Nov. 26, 2018

FDA approves Daurismo for newly diagnosed AML ineligible for intensive chemotherapy

Nov. 22, 2018

FDA grants accelerated approval to Venclexta for newly diagnosed AML

Nov. 22, 2018

FDA approves Gamifant for primary hemophagocytic lymphohistiocytosis

Nov. 21, 2018

FDA approves Aemcolo for the treatment of travelers' diarrhea

Nov. 19, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...